Manning Paul B bought VRCA
November 25, 2025 · Form 4 insider transaction
Manning Paul B bought 2,750,762 shares of Verrica Pharmaceuticals Inc. at $4.24 per share, a transaction worth $11.67M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,750,762
Price
$4.24
Total value
$11.67M
InsiderManning Paul B
RoleDirector, 10% owner
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateNovember 25, 2025
Filing dateNovember 25, 2025
Shares owned after3,348,372
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Effective July 24, 2025, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split.; The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of the manager of BKB and has shared voting and investment power with respect to the shares held by BKB.